These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
136 related articles for article (PubMed ID: 20829824)
1. Global health or global wealth? Rezaie R; Singer PA Nat Biotechnol; 2010 Sep; 28(9):907-9. PubMed ID: 20829824 [No Abstract] [Full Text] [Related]
2. The National Institutes of Health Small Business Innovation Research (SBIR) Program: opportunities for orphan drug development. Engstrom LO Prog Clin Biol Res; 1985; 197():25-30. PubMed ID: 4070295 [No Abstract] [Full Text] [Related]
4. The economics of orphan drug policy in the US. Can the legislation be improved? Peabody JW; Ruby A; Cannon P Pharmacoeconomics; 1995 Nov; 8(5):374-84. PubMed ID: 10160072 [TBL] [Abstract][Full Text] [Related]
5. Adoption agent. Peota C Minn Med; 2005 Mar; 88(3):8-9. PubMed ID: 15852583 [No Abstract] [Full Text] [Related]
6. Introduction-Current activities and future goals of orphan disease agencies. Van Woert MH Prog Clin Biol Res; 1985; 197():3-6. PubMed ID: 4070296 [No Abstract] [Full Text] [Related]
7. Drug legislation. Drug companies divided. Gershon D Nature; 1990 May; 345(6270):6. PubMed ID: 2330052 [No Abstract] [Full Text] [Related]
8. Improving access to medicines in poor countries: the role of universities. Chokshi DA PLoS Med; 2006 Apr; 3(6):e136. PubMed ID: 16608382 [TBL] [Abstract][Full Text] [Related]
16. Billion-dollar orphans: prescription for trouble. Gibbons A Science; 1990 May; 248(4956):678-9. PubMed ID: 2333518 [No Abstract] [Full Text] [Related]
17. Prescription for the Orphan Drug Act: the impact of the FDA's 1992 regulations and the latest congressional proposals for reform. Clissold DB Food Drug Law J; 1995; 50(1):125-47. PubMed ID: 10342989 [No Abstract] [Full Text] [Related]
18. Pharmaceuticals. Adopt an orphan. Karr A Health Serv J; 1999 Nov; 109(5681):28. PubMed ID: 10724720 [No Abstract] [Full Text] [Related]